FILE - This April 30, 2020, file photo shows Gilead Sciences headquarters in Foster City, Calif. The European Medicines Agency says it has started a safety review after some patients taking the coronavirus drug remdesivir reported serious kidney problems. In a statement on Friday, Oct. 2, 2020, the EU regulator said it isn’t clear whether remdesivir is causing the “acute kidney injury,” but that the issue “warrants further investigation.” Remdesivir is one of the few licensed treatments for the coronavirus, in additional to the generic steroid dexamethasone. In July, health experts criticized the U.S. for buying up a significant portion of the drug, made by Gilead Sciences. (AP Photo/Ben Margot, File)
Featured Photo Galleries
Military parade celebrates Army’s 250th
Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.
Ovi scores goal 890, Caps lose to Sabres 8-5
Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)
Hegseth joins veterans, generals to mark 80th anniversary of battle of Iwo Jima
A handful of retired Marines – all in the late 90s or over 100 — joined Defense Secretary Pete Hegseth and Japan’s Prime Minister Takeru Ishida on Saturday to mark the anniversary of one of the bloodiest battles of World War II in the Pacific that ended 80 years ago this week.
